Botulinum toxin injections into the salivary glands to reduce drooling in childre

Phase 4

Recruiting

• Conditions: Excessive drooling in children with neurological disorders; Neurological - Other neurological disorders

• Registration Number: ACTRN12605000379617
• Lead Sponsor: Murdoch Children's Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

Problem with drooling Guardians able to understand study requirements and give informed consent.

Exclusion Criteria

Previous botulinum toxin therapy to salivary glandsPrevious saliva control surgeryAny BTX-A treatment in previous 6 monthsNot fit enough to undergo general anaesthesiaUnwillingness to go off drooling medication for length of study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Questionnaire on frequency, severity and impact of drooling will be administered by phone[At one month post injection, and each successive month for 6 months]

Secondary Outcome Measures

Name	Time	Method
one[]